Diabetes Self-Management Blog

Metformin (brand names Glucophage, Glucophage XR, Fortamet, Riomet, Glumetza, and others) is believed to be the most commonly prescribed diabetes medicine in the world, with more than 48 million prescriptions written in 2010 in the United States alone. Now, new research from the University of Gothenburg in Sweden suggests that this drug may be useful for treating even more people than previously thought.

Metformin is an oral medicine for Type 2 diabetes that belongs to a drug class known as biguanides. It helps lower blood glucose levels by making muscle and fat cells more sensitive to insulin and by preventing the liver from making excess glucose. The medicine also lowers triglyceride (blood fat) and cholesterol levels and does not cause weight gain. Beyond lowering blood glucose and lipid levels, research has suggested that metformin may reduce the risk of death in people with Type 2, lower cancer risk, increase lifespan, and improve heart health.

Although metformin is generally considered safe, it has been known to cause a rare but serious side effect called lactic acidosis (a condition in which lactic acid builds up faster in the bloodstream than it can be removed), and so is not prescribed to people with reduced kidney function. But recently, researchers in Sweden looked at nearly 51,700 men and women with Type 2 diabetes from the Swedish national diabetes register who were being treated with oral diabetes medicines or insulin and who had varying degrees of kidney function.

The researchers discovered that the risks of metformin to people with mild kidney impairment have been overstated. They also found that metformin was more effective than other blood-glucose-lowering drugs at reducing the risk of cardiovascular disease, serious infection, and death in people with both normal kidney function and with mild kidney impairment.

“Patients with mild to moderate kidney impairment do not run an elevated risk of adverse effects from metformin. Thus, the drug can be prescribed for many more patients with diabetes than is currently the case,” noted study author Nils Ekström, who added that various countries already recommend metformin for people who have mild kidney impairment. He further noted, however, that “Metformin still cannot be recommended for patients with severe kidney impairment and should be prescribed with great caution for those patients.”

To learn more about the research, read the article “Considerably More Patients May Benefit From Antidiabetic Drug, Study Suggests” or see the study in the journal BMJ Open. And for more information about metformin, read the entry on this medicine in our series, “Diabetes Drugs.”

POST A COMMENT       
  

Comments
  1. Dianne: Thank you most kindly for latest data on metformin and its benefits. I am pleased to see updates like this that help expand our knowledge and experience on this most curious of drugs.

    Posted by jim snell |
  2. It may be a useful drug, but for some people (such as me) it causes horrible diarrhea. I had bouts of explosive diarrhea for almost 9 YEARS before I finally started Lantus injections instead so that I could take part in a study to find out the cause of the diarrhea; the diarrhea disappeared and has been gone for a year now that I am using insulin instead.

    Posted by Angela Bunke |
  3. My doctor put me on 500mg of metaformin which he said to take them both at supper time. I notice at night I get a tickle in my throat and am coughing. Just wondering if I would take one of the pills mid morning and the other one close to supper if that would help on the coughing. As when I take them both in the evening, I am up and down all night urinating. Even thought about taking just one a day. Need advice as I am new to this. When I take my sugar readings they are 92 to 124 and some of the low readings is when I forget to take my metaformin or it is too late in the evening to take it. Thank you ahead. Sue

    Posted by Sue Harris |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.


Oral Medicines
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
New SGLT Drugs Coming (07/23/14)

Diabetes Research
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)

Diabetes News
FDA Approves Remote Glucose-Monitoring Technology (10/23/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)

Diane Fennell
FDA Approves Remote Glucose-Monitoring Technology (10/23/14)
Can Grapefruit Juice Prevent Weight Gain, Increase Insulin Sensitivity? (10/16/14)
Low-Carb Diet Improves Quality of Life in Type 2 Diabetes (10/07/14)
Long Hours at Low-Income Jobs Linked to Increased Diabetes Risk (10/02/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.